StemoniX's Series A - II Round

StemoniX raised a round of funding on August 22, 2018. Investors include Brightstone Venture Capital.

StemoniX provides products and services for drug discovery and development. It structures human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic …

Articles about StemoniX's Series A - II Round: